Pharmacists in Sandpoint, ID Accepting Medicare

26 Pharmacists found. Showing 21 - 26

Lori Jean Howard, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1319 Highway 2 Ste A, Sandpoint, ID 83864 Phone: 208-263-9080    Fax: 208-255-1695

Sara Couch Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 520 N 3rd Ave, Sandpoint, ID 83864 Phone: 208-265-3731    Fax: 208-265-1031

Logan Woolson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 604 N Fifth Ave, Sandpoint, ID 83864 Phone: 208-263-1408

Kendall Anne Yake, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1319 Highway 2, Suite A, Sandpoint, ID 83864 Phone: 208-263-9080    Fax: 208-255-1695

Cody Ray, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 702 N Fifth Ave, Sandpoint, ID 83864 Phone: 208-263-8923

Dr. Robert Stephen Olsen, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 780 Selkirk Rd, Sandpoint, ID 83864 Phone: 208-263-7749    Fax: 208-263-4673

News Archive

Pieris achieves milestone in Anticalin discovery and development collaboration with Daiichi Sankyo

Pieris AG announced today the achievement of the first financial milestone in its discovery and development collaboration with Daiichi Sankyo Company Limited.

CINJ urologic oncology chief completes 1,000th robotic prostatectomy at RWJUH

Marking a major milestone in what has become a fast-growing standard of care in prostate cancer surgery, the chief of urologic oncology at The Cancer Institute of New Jersey has completed his 1,000th robotic prostatectomy at Robert Wood Johnson University Hospital (RWJUH), the Flagship Hospital of The Cancer Institute of New Jersey, which is a Center of Excellence of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School.

Prenatal biochemical screening only detects half of chromosomal abnormalities

Prenatal biochemical screening tests are widely used to look for chromosomal abnormalities in the fetus which can lead to serious handicap, or even death during gestation or in the first few days after birth. But these tests are only able to detect fewer than half of the total chromosomal abnormalities in the fetus, a scientist will tell the annual conference of the European Society of Human Genetics tomorrow (Monday 2 June) Dr. Francesca R. Grati, of the TOMA Laboratory, Busto Arsizio, Italy, says that these findings mean that women should be better informed on the limitations of such diagnostic tests.

FDA issues PMA response letter to BioMimetic's Augment Bone Graft

BioMimetic Therapeutics, Inc. announced today that it received a comprehensive post-panel response letter from the FDA related to the Company's Pre-Market Approval (PMA) application for Augment Bone Graft for use as an alternative to autograft in hindfoot and ankle fusion procedures.

Data reinforces SAB-185's potential to neutralize SARS-CoV-2 variants

A study, available on the pre-print server bioRxiv*, evaluated the neutralizing capacity of a fully human polyclonal antibody (SAB-185) against the Delta, Kappa, and Lambda variants using a lentiviral-based pseudovirus assay.

Read more Medical News

› Verified 9 days ago

• 1
• 2(current)